Diagnostic test property of transcription-reverse transcription concerted reaction reagent TRCReady® SARS-CoV-2 i using nasopharyngeal swab samples

Ogawa, Megumi; Sato, Mitsuru; Yamakami, Asuka; Hayasaka, Yuki; Saya, Yoshiko; Une, Kurando; Iwai, Satoshi; Tsuchiya, Shunji; Mikami, Yumiko; Fukazawa, Chizumi; Uehara, Yuki

doi:10.1016/j.jiac.2022.09.019

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When someone is infected with COVID-19, that person will show symptoms of fever and at least signs of respiratory illness, such as coughing and shortness of breath, and require hospitalization. Diagnosis is made base.d on the results In NAAT, the recommended method is a Real-Time Reverse-Transcription Polymerase Chain Reaction [4]. In addition to NAAT, hematological examination is also essential for disease progression.…”

Section: Introductionmentioning

confidence: 99%

Characteristics of D-Dimer Levels in Patients Confirmed Positive for COVID-19 Aged 45 – 70 Years at UKI Hospital for the Period December 2020 – September 2021

Luhulima,

Saluntondok,

Irwan

2024

JOCAMR

View full text Add to dashboard Cite

COVID-19 is a disease caused by the SARS-CoV-2 virus. COVID-19 is divided into several clinical symptoms based on a person's experiences. In severe clinical signs of COVID-19, D –Dimer will be significantly higher. This study aims to determine D-Dimer levels in COVID-19 patients aged 45 – 70 and uses a descriptive-analytic method with a retrospective cross-sectional design. The number of samples was 198 patients whose D-Dimer levels were checked and 127 patients who received anticoagulant prophylaxis. The research samples were all medical records of patients suffering from COVID-19 aged 45 - 70 years and who had checked D-Dimer levels at RSU UKI from December 2020 to September 2021 found that 145 patients (73.2%) had normal D-Dimer levels, 53 patients (26.8%) had increased D-Dimer levels. The distribution of women were 100 patients (50.5%), and men were 98 patients (49.5%), the highest range was aged 54 - 62 years with 74 patients (37.4%), clinical symptoms were being experienced by 122 patients (61.6%), and comorbid hypertension was the most common disease with 64 patients (32.3%). A significant relationship was found between D-Dimer levels and comorbidities (p=0.04). Anticoagulant prophylaxis was given to 127 patients, with mild symptoms experienced by five patients (3.6%), moderate symptoms experienced by 73 patients (57.5%), and severe symptoms experienced by 49 patients (38.6%). However, no significant relationship was found (p=0.66) between administering anticoagulant prophylaxis and D-Dimer levels in patients with mild, moderate, or severe symptoms.

show abstract

Section: Introductionmentioning

confidence: 99%